NovoCure Limited (NVCR)
NASDAQ: NVCR · Real-Time Price · USD
16.86
+0.38 (2.31%)
At close: Nov 20, 2024, 4:00 PM
17.08
+0.22 (1.30%)
Pre-market: Nov 21, 2024, 7:41 AM EST
NovoCure Market Cap
NovoCure has a market cap or net worth of $1.82 billion as of November 21, 2024. Its market cap has increased by 32.65% in one year.
Market Cap
1.82B
Enterprise Value
1.54B
1-Year Change
32.65%
Ranking
Category
Stock Price
$16.86
Market Cap Chart
Since October 2, 2015, NovoCure's market cap has increased from $1.51B to $1.82B, an increase of 20.71%. That is a compound annual growth rate of 2.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 1.82B | 14.35% |
| Dec 29, 2023 | 1.60B | -79.28% |
| Dec 30, 2022 | 7.70B | -1.24% |
| Dec 31, 2021 | 7.79B | -55.75% |
| Dec 31, 2020 | 17.62B | 111.21% |
| Dec 31, 2019 | 8.34B | 167.82% |
| Dec 31, 2018 | 3.11B | 72.52% |
| Dec 29, 2017 | 1.81B | 164.99% |
| Dec 30, 2016 | 681.20M | -63.57% |
| Dec 31, 2015 | 1.87B | 23.71% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Structure Therapeutics | 1.87B |
| Harmony Biosciences Holdings | 1.87B |
| Disc Medicine | 1.86B |
| NewAmsterdam Pharma Company | 1.85B |
| Evotec SE | 1.85B |
| RxSight | 1.81B |
| Tarsus Pharmaceuticals | 1.78B |
| Integra LifeSciences Holdings | 1.77B |